EMERYVILLE, Calif. (AP) _ Adamas Pharmaceuticals Inc. (ADMS) on Monday reported a loss of $12.3 million in its second quarter.

On a per-share basis, the Emeryville, California-based company said it had a loss of 27 cents.

The results met Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was also for a loss of 27 cents per share.

The drugmaker posted revenue of $22 million in the period, missing Street forecasts. Five analysts surveyed by Zacks expected $22.2 million.

Adamas shares have risen 20% since the beginning of the year. In the final minutes of trading on Monday, shares hit $5.18, a rise of 37% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADMS at https://www.zacks.com/ap/ADMS

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News